Sapphiros Awarded $11M from NIH RADx® Tech to Develop a Next-generation Molecular OTC Test

BOSTON, Apr. 17, 2023 /PRNewswire/ — Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has been selected by the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program to develop a high performance, over-the-counter (OTC), molecular multiplex respiratory diagnostic test that can […]